Home/Filings/4/0001171843-17-005396
4//SEC Filing

GOLDENBERG CYNTHIA L 4

Accession 0001171843-17-005396

CIK 0000722830other

Filed

Sep 4, 8:00 PM ET

Accepted

Sep 5, 7:10 PM ET

Size

9.0 KB

Accession

0001171843-17-005396

Insider Transaction Report

Form 4
Period: 2017-08-31
GOLDENBERG CYNTHIA L
DirectorPresident and CEO10% Owner
Transactions
  • Sale

    Common Stock

    2017-08-31$12.25/sh5,000$61,250793,219 total
  • Sale

    Common Stock

    2017-08-31$12.50/sh5,000$62,500788,219 total
  • Sale

    Common Stock

    2017-09-01$12.90/sh10,000$129,000778,219 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    5,128,014
Footnotes (2)
  • [F1]Includes a total of 635,935 shares held as joint tenants by the reporting person and her spouse, David M. Goldenberg, a director of the issuer and the Issuer's Chief Scientific Officer and Chief Patent Officer.
  • [F2]Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interests therein.

Issuer

IMMUNOMEDICS INC

CIK 0000722830

Entity typeother

Related Parties

1
  • filerCIK 0001202016

Filing Metadata

Form type
4
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 7:10 PM ET
Size
9.0 KB